Medical management of frontotemporal dementias: The importance of the caregiver in symptom assessment and guidance of treatment strategies

Medicine and Dentistry

• Therapeutic Procedure 100%
• Caregiver 100%
• Symptom Assessment 100%
• Frontotemporal Lobar Degeneration 100%
• Therapeutics 80%
• Symptom 60%
• Patient 40%
• Person 40%
• Cognition 40%
• Selective Serotonin Reuptake Inhibitor 40%
• Diseases 20%
• Drug Therapy 20%
• Physician 20%
• Comprehension 20%
• Drug 20%
• Clinician 20%
• Analeptic 20%
• N-Methyl-D-Aspartic Acid 20%
• Parkinsonism 20%
• Caregiver Burden 20%
• Acetylcholinesterase Inhibitor 20%
• Pseudobulbar Affect 20%
• Motor Neuron Disease 20%
• Monoamine Oxidase Inhibitor 20%
• Typical Antipsychotic 20%
• Mood Stabilizer 20%
• Antidepressant 20%
• Antihypertensive 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Symptom 100%
• Frontotemporal Dementia 100%
• Selective Serotonin Reuptake Inhibitor 40%
• Mood Stabilizer 20%
• Stimulant 20%
• Drug Discovery 20%
• Antidepressant 20%
• Monoamine Oxidase Inhibitor 20%
• Cholinesterase Inhibitor 20%
• Motor Neuron Disease 20%
• Disease 20%
• Aspartic Acid 20%
• Typical Antipsychotic 20%
• Parkinsonism 20%
• Antihypertensive 20%

Neuroscience

• Frontotemporal Dementia 100%
• Selective Serotonin Reuptake Inhibitor 40%
• Cognition 20%
• Antidepressant 20%
• N-Methyl-D-Aspartic Acid 20%
• Analeptic 20%
• Parkinsonism 20%
• Mood Stabilizer 20%
• Acetylcholinesterase Inhibitor 20%
• Motor Neuron Disease 20%
• Typical Antipsychotic 20%
• Monoamine Oxidase Inhibitor 20%